On the mechanism by which 4-aminopyridine occludes quinidine block of the cardiac K+ channel, hKv1.5

Journal of General Physiology

Volumn 111, Issue 4, 1998, Pages 539-554

  Chen, Fred S P ^a   Fedida, David ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Channel block; Gating currents; Heart; Potassium channel

Indexed keywords

4 AMINOPYRIDINE; POTASSIUM CHANNEL; QUINIDINE;

ARTICLE; CELL MEMBRANE DEPOLARIZATION; CHANNEL GATING; HEART; HEART REPOLARIZATION; HUMAN; HUMAN CELL;

4-AMINOPYRIDINE; ANTI-ARRHYTHMIA AGENTS; CELL LINE; ELECTRIC CONDUCTIVITY; HUMANS; ION CHANNEL GATING; KV1.5 POTASSIUM CHANNEL; MYOCARDIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; QUINIDINE; TIME FACTORS;

EID: 0031947419     PISSN: 00221295     EISSN: None     Source Type: Journal    
DOI: 10.1085/jgp.111.4.539     Document Type: Article

References (53)

1. Armstrong, C.M. 1971. Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axon. J. Gen. Physiol. 58:413-437.
2. Armstrong, C.M., and F. Bezanilla. 1977. Inactivation of the sodium channel. II. Gating current experiments. J. Gen. Physiol. 70:567-590.
3. Bezanilla, F., E. Perozo, D.M. Papazian, and E. Stefani. 1991. Molecular basis of gating charge immobilization in Shaker potassium channels. Science. 254:679-683.
4. + channels: II. The components of gating currents and a model of channel activation. Biophys. J. 66:1011-1021.
5. Bouchard, R.A., and D. Fedida. 1995. Closed and open state binding of 4-aminopyridine to the cloned human potassium channel Rv1.5. J. Pharmacol. Exp. Ther. 275:864-876.
6. Campbell, D.L., Y. Qu, R.L. Rasmusson, and H.C. Strauss. 1993. The calcium-independent transient outward potassium current in isolated ferret right ventricular myocytes. II. Closed state reverse use-dependent block by 4-aminopyridine. J. Gen. Physiol. 101:603-626.
7. Castle, N.A., S.R. Fadous, D.E. Logothetis, and G.K. Wang. 1994. 4-aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels. Mol. Pharmacol. 46:1175-1181.
8. + current in adult rat ventricular myocytes. J. Pharmacol. Exp. Ther. 264:1450-1459.
9. + channel deactivation. J. Gen. Physiol. 110:87-100.
10. Cheti, F.S.P., and D. Fedida. 1996. Gating current measurements show that 4-aminopyridine prevents open channel block of Kv1.5 by quinidine. Neuropharmacology. 35:82. (Abstr.)
11. Choquet, D., and H. Korn. 1992. Mechanism of 4-aminopyridine action on voltage-gated potassium channels in lymphocytes. J. Gen. Physiol. 99:217-240.
12. + current in rat ventricle. Br. J. Pharmacol. 115:335-343.
13. Clarkson, C.W., and L.M. Hondeghem. 1985. Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine assodated with cardiac sodium channels in guinea pig ventricular myocardium. Circ. Res. 56:496-506.(Abstr.)
14. Colatsky, T.J. 1982. Mechanisms of action of lidocaine and quinidine on action potential duration in rabbit cardiac Purkinje fibers. Circ. Res. 50:17-27.(Abstr.)
15. + channel behaves like an open-channel blocker. Neuron. 7:743-753.
16. + channel current. Circ. Res. 73:210-216.
17. Fedida, D., R. Bouchard, and F.S.P. Chen. 1996. Slow gating charge immobilization in the human potassium channel Kv1.5 and its prevention by 4-aminopyridine. J. Physiol. (Camb.). 494:377-387.
18. + channels. J. Physiol. (Camb.). 499:661-675.
19. Gillespie, J.I., and O.F. Hutter. 1975. Proceedings: the actions of 4-aminopyridine on the delayed potassium current in skeletal muscle fibres. J. Physiol. (Camb.). 252:70P-71P.
20. + channels: evidence for a trap door mechanism of activation gating. J. Gen. Physiol. 109:527-535.
21. Hurst, R.S., L. Toro, and E. Stefani. 1996. Molecular determinants of external barium block in Shaker potassium channels. FEBS Lett. 388:59-65.
22. Hurst, R.S., M.J. Roux, L. Toro, and E. Stefani. 1997. External barium influences the gating charge movement of Shaker potassium channels. Biophys. J. 72:77-84.
23. Imaizumi, Y., and W.R. Giles. 1987. Quinidine-induced inhibition of a transient outward current in cardiac muscle. Am. J. Physiol. 253:H704-H709.
24. + current in rat melanotrophs. J. Physiol. (Camb.). 431:515-528.
25. + current in rat melanotrophs. Br. J. Pharmacol. 103: 1807-1813.
26. Kenyon, J.L., and W.R. Gibbons. 1979. 4-Aminopyridine and the early outward current of sheep cardiac Purkinje fibers. J. Gen. Physiol. 73:139-157.
27. + pores. Neuron. 11:503-512.
28. Kirsch, G.E., and J.A. Drewe. 1993. Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels. J. Gen. Physiol. 102:797-816.
29. Kirsch, G.E., and T. Narahashi. 1983. Site of action and active form of aminopyridines in squid axon membranes. J. Pharmacol. Exp. Ther. 226:174-179.
30. + channels. Neuron. 12:301-315.
31. + channels. Implications for activation and inactivation models. Biophys. J. 62:160-171.
32. + channels. Neuron. 11:353-358.
33. Philipson, L.H., A. Malayev, A. Kuznetsov, C. Chang, and D.J. Nelson. 1993. Functional and biochemical characterization of the human potassium channel Kv1.5 with a transplanted carboxyl-terminal epitope in stable mammalian cell lines. Biochim. Biophys. Acta. 1153:111-121.
34. + channel (Kv1.4) cloned from ferret ventricle and expressed in Xenopus oocytes. J. Physiol. (Camb.). 485:59-71.
35. + channels. J. Gen. Physiol. 109:767-778.
36. Simurda, J., M. Simurdová, and G. Christe. 1989. Use-dependent effects of 4-aminopyridine on transient outward current in dog ventricular muscle. Pflügers Arch. 415:244-246.
37. + channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J. Pharmacol. Exp. Ther. 269:66-74.(Abstr.)
38. Snyders, D.J., K.M. Knoth, S.L. Roberds, and M.M. Tamkun. 1992. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol. Pharmacol. 41:322-330.
39. Snyders, D.J., and S.W. Yeola. 1995. Determinants of antiarrhythmic drug action: electrostatic and hydro-phobic components of block of the human cardiac hKv1.5 channel. Circ. Res. 77:575-583.
40. + channels: I. Ionic and gating currents. Biophys. J. 66: 996-1010.
41. Stephens, G.J., J.C. Garratt, B. Robertson, and D.G. Owen. 1994. On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1. J. Physiol. (Camb.). 477: 187-196.
42. Stühmer, W., F. Conti, M. Stocker, O. Pongs, and S.H. Heinemann. 1991. Gating currents of inactivating and non-inactivating potassium channel expressed in Xenopus oocytes. Pflügers Arch. 410: 423-429.
43. + channel DRK1. Proc. Natl. Acad. Sci. USA. 90: 4758-4762.
44. Thompson, S. 1982. Aminopyridine block of transient potassium current. J. Gen. Physiol. 80:1-18.
45. Tseng, G.N., B. Zhu, S. Ling, and J.A. Yao. 1996. Quinidine enhances and suppresses Kv1.2 from outside and inside the cell, respectively. J. Pharmacol. Exp. Ther. 279:844-855.
46. Ulbricht, W., and H.H. Wagner. 1976. Block of potassium channels of the nodal membrane by 4-aminopyridine and its partial removal on depolarization. Pflügers Arch. 367:77-87.
47. Wagoner, P.K., and G.S. Oxford. 1990. Aminopyridines block an inactivating potassium current having slow recovery kinetics. Biophys. J. 58:1481-1489.
48. Wang, Z., B. Fermini, and S. Nattel. 1995. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J. Pharmacol. Exp. Ther. 272:184-196.
49. + channel currents by quinidine. Circ. Res. 73:351-359.
50. Yeh, J.Z., G.S. Oxford, and C.H. Wu. 1976. Dynamics of aminopyridine block of potassium channels in squid axon membrane. J. Gen. Physiol. 68:519-535.
51. + channel: role of S6 in antiarrhythmic drug binding. Circ. Res. 78:1105-1114.
52. Zagotta, W.N., T. Hoshi, and R.W. Aldrich. 1994a. Shaker potassium channel gating. III. Evaluation of kinetic models for activation. J. Gen. Physiol. 103:321-362.
53. Zagotta, W.N., T. Hoshi, J. Dittman, and R.W. Aldrich. 1994b. Shaker potassium channel gating. II. Transitions in the activation pathway. J. Gen. Physiol. 103:279-319.